Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Developing therapeutic antibodies often requires multiple rounds of optimization after initial discovery. Many antibody programs face costly redesign cycles because key parameters such as affinity, developability, specificity, or manufacturability were not sufficiently addressed early in the process. These redesign cycles can significantly extend timelines, increase costs, and delay the progression of promising therapeutic candidates.
In this webinar, we will explore how integrated discovery and engineering strategies can help teams progress from initial hits to optimized lead candidates in under 12 months. Using real-world program insights, we will discuss how early developability assessment, multiparametric optimization, and platform integration can reduce downstream risk and accelerate antibody programs toward development.
Presenters
Maria Pajuelo
Dr. Maria Pajuelo is Co-founder and EVP of Technology and Scientific Office at FairJourney Bio. She leads the development and integration of advanced antibody discovery and engineering platforms that support biotech and pharmaceutical partners in accelerating therapeutic antibody programs. With extensive experience in antibody technologies and discovery strategies, her work focuses on enabling efficient transitions from antibody discovery to optimized lead candidates while minimizing development risks.
Sponsor
KACTUS
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
